Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taroh Satoh

Showing results (11-20 of 277) with videos related to

Pageof 28
Sort By:
Cancer Chemotherapy and Pharmacology|July 19, 2012
Pharmacokinetics of sepantronium bromide (YM155), a small-molecule suppressor of survivin, in Japanese patients with advanced solid tumors: dose proportionality and influence of renal impairmentYumiko Aoyama, Tetsuya Nishimura, Taiji Sawamoto, et al.
International Journal of Clinical Oncology|April 30, 2020
Practical guidance for the evaluation of disease progression and the decision to change treatment in patients with advanced gastric cancer receiving chemotherapySatoru Iwasa, Toshihiro Kudo, Daisuke Takahari, et al.
Nihon Geka Gakkai Zasshi|May 16, 2012
[The concept and significance of cancer stem cells]Naotsugu Haraguchi, Hideshi ishii, Daisuke Sakai, et al.
Lung Cancer (Amsterdam, Netherlands)|September 26, 2006
Pemetrexed-induced edema of the eyelidTakayasu Kurata, Kenji Tamura, Isamu Okamoto, et al.
International Journal of Clinical Oncology|June 24, 2020
Correction to: Practical guidance for the evaluation of disease progression and the decision to change treatment in patients with advanced gastric cancer receiving chemotherapySatoru Iwasa, Toshihiro Kudo, Daisuke Takahari, et al.
Cancer Letters|September 9, 2006
Down-regulation of survivin by ultraviolet C radiation is dependent on p53 and results in G(2)-M arrest in A549 cellsMasato Ikeda, Isamu Okamoto, Kenji Tamura, et al.
Japanese Journal of Clinical Oncology|September 8, 2010
Multicentre phase II study of XELOX with bevacizumab in late-stage elderly patients with unresectable advanced/recurrent colorectal cancer: an ASCA studyKoji Oba, Masaki Matsuoka, Taroh Satoh, et al.
Cancer Chemotherapy and Pharmacology|November 26, 2011
Pharmacokinetic analysis of capecitabine and cisplatin in combination with trastuzumab in Japanese patients with advanced HER2-positive gastric cancerTaroh Satoh, Yasushi Omuro, Yasutsuna Sasaki, et al.
Anticancer Research|September 12, 2013
Pharmacokinetic assessment of irinotecan, SN-38, and SN-38-glucuronide: a substudy of the FIRIS studyTaroh Satoh, Hirofumi Yasui, Kei Muro, et al.
International Journal of Clinical Oncology|October 26, 2020
Impact of sarcopenia in patients with advanced or recurrent colorectal cancer treated with regorafenibYasushi Murachi, Daisuke Sakai, Jun Koseki, et al.
Pageof 28

Showing results (11-20 of 277) with videos related to

Sort By:
Pageof 28
Cancer Chemotherapy and Pharmacology|July 19, 2012
Pharmacokinetics of sepantronium bromide (YM155), a small-molecule suppressor of survivin, in Japanese patients with advanced solid tumors: dose proportionality and influence of renal impairmentYumiko Aoyama, Tetsuya Nishimura, Taiji Sawamoto, et al.
International Journal of Clinical Oncology|April 30, 2020
Practical guidance for the evaluation of disease progression and the decision to change treatment in patients with advanced gastric cancer receiving chemotherapySatoru Iwasa, Toshihiro Kudo, Daisuke Takahari, et al.
Nihon Geka Gakkai Zasshi|May 16, 2012
[The concept and significance of cancer stem cells]Naotsugu Haraguchi, Hideshi ishii, Daisuke Sakai, et al.
Lung Cancer (Amsterdam, Netherlands)|September 26, 2006
Pemetrexed-induced edema of the eyelidTakayasu Kurata, Kenji Tamura, Isamu Okamoto, et al.
International Journal of Clinical Oncology|June 24, 2020
Correction to: Practical guidance for the evaluation of disease progression and the decision to change treatment in patients with advanced gastric cancer receiving chemotherapySatoru Iwasa, Toshihiro Kudo, Daisuke Takahari, et al.
Cancer Letters|September 9, 2006
Down-regulation of survivin by ultraviolet C radiation is dependent on p53 and results in G(2)-M arrest in A549 cellsMasato Ikeda, Isamu Okamoto, Kenji Tamura, et al.
Japanese Journal of Clinical Oncology|September 8, 2010
Multicentre phase II study of XELOX with bevacizumab in late-stage elderly patients with unresectable advanced/recurrent colorectal cancer: an ASCA studyKoji Oba, Masaki Matsuoka, Taroh Satoh, et al.
Cancer Chemotherapy and Pharmacology|November 26, 2011
Pharmacokinetic analysis of capecitabine and cisplatin in combination with trastuzumab in Japanese patients with advanced HER2-positive gastric cancerTaroh Satoh, Yasushi Omuro, Yasutsuna Sasaki, et al.
Anticancer Research|September 12, 2013
Pharmacokinetic assessment of irinotecan, SN-38, and SN-38-glucuronide: a substudy of the FIRIS studyTaroh Satoh, Hirofumi Yasui, Kei Muro, et al.
International Journal of Clinical Oncology|October 26, 2020
Impact of sarcopenia in patients with advanced or recurrent colorectal cancer treated with regorafenibYasushi Murachi, Daisuke Sakai, Jun Koseki, et al.
Pageof 28